OSE Immunotherapeutics Reports Full Year 2024 Financial Results and Provides Corporate Update Total income of €83.4 million. Cash level of €64.2 ...

A decision on tolebrutinib for treating MS is now set for Sept. 28, after the FDA granted priority review to its approval ...

By hoodwinking seniors into private Medicare Advantage plans, insurers profit by denying care and bankrupting hospitals.

There are already more than 20,000 people on ADHD waiting lists in the region, and figures could increase even further by at ...

In an interview, Scholar Rock's chief medical officer talks about benefits seen in clinical trials of its muscle-targeted SMA therapy.

There was a large police presence in Brunswick Village on Wednesday morning following a 999 call-out, which also involved firefighters and ambulance crews. Police officers could be seen conducting ...

Liverpool struggled in front of goal before the international break but a number of Arne Slot's forwards might have just ...

Leila Green, 41, from London welcomed her triplet sons in 2022 after conceiving naturally but has since faced a barrage of ...

However, its presence is steadily dropping, according to local drug-checking program data. The Philadelphia Department of Public Health says medetomidine has emerged as a primary adulterant and is now ...

Lancashire health trust which was heavily criticised over the death of baby Ida Lock paid almost three quarters of a million ...

The live webcast can be accessed in the investors section of the MBX Biosciences website at https://investors.mbxbio.com/news-events/events. Access to the webcast replay will be available ...

Childhood-onset striatonigral neurodegeneration robs children of the ability to walk and talk by age five. Researchers at ...